Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Powell

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Bone Research|August 15, 2015
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypesRobert Brommage, Jeff Liu, Gwenn M Hansen, et al.
Genetics|January 29, 2016
Segregation of Naturally Occurring Mitochondrial DNA Variants in a Mini-Pig ModelGael Cagnone, Te-Sha Tsai, Kanokwan Srirattana, et al.
Stem Cell Reports|March 1, 2016
A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem CellsChristian M Nefzger, Thierry Jardé, Fernando J Rossello, et al.
Endocrinology|May 19, 2011
Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in miceCheryl A Conover, Henning B Boldt, Laurie K Bale, et al.
Journal of Bacteriology|March 24, 2022
The Role and Targets of the RNA-Binding Protein ProQ in the Gram-Negative Bacterial Pathogen Pasteurella multocidaEmily L Gulliver, Brandon M Sy, Julia L Wong, et al.
Clinical Cardiology|May 1, 2013
Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapyPablo Lapuerta, Julio Rosenstock, Brian Zambrowicz, et al.
Diabetes, Obesity & Metabolism|February 14, 2023
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney diseaseDavid Z I Cherney, Ele Ferrannini, Guillermo E Umpierrez, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2013
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucoseDavid R Powell, Melinda Smith, Jennifer Greer, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2012
Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiationGabriel R Linares, Robert Brommage, David R Powell, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Bone Research|August 15, 2015
High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypesRobert Brommage, Jeff Liu, Gwenn M Hansen, et al.
Genetics|January 29, 2016
Segregation of Naturally Occurring Mitochondrial DNA Variants in a Mini-Pig ModelGael Cagnone, Te-Sha Tsai, Kanokwan Srirattana, et al.
Stem Cell Reports|March 1, 2016
A Versatile Strategy for Isolating a Highly Enriched Population of Intestinal Stem CellsChristian M Nefzger, Thierry Jardé, Fernando J Rossello, et al.
Endocrinology|May 19, 2011
Pregnancy-associated plasma protein-A2 (PAPP-A2): tissue expression and biological consequences of gene knockout in miceCheryl A Conover, Henning B Boldt, Laurie K Bale, et al.
Journal of Bacteriology|March 24, 2022
The Role and Targets of the RNA-Binding Protein ProQ in the Gram-Negative Bacterial Pathogen Pasteurella multocidaEmily L Gulliver, Brandon M Sy, Julia L Wong, et al.
Clinical Cardiology|May 1, 2013
Study design and rationale of a dose-ranging trial of LX4211, a dual inhibitor of SGLT1 and SGLT2, in type 2 diabetes inadequately controlled on metformin monotherapyPablo Lapuerta, Julio Rosenstock, Brian Zambrowicz, et al.
Diabetes, Obesity & Metabolism|February 14, 2023
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney diseaseDavid Z I Cherney, Ele Ferrannini, Guillermo E Umpierrez, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2013
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucoseDavid R Powell, Melinda Smith, Jennifer Greer, et al.
Veterinary Pathology|July 9, 2020
Progressive Degenerative Myopathy and Myosteatosis in ASNSD1-Deficient MicePeter Vogel, Zhi-Ming Ding, Robert Read, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2012
Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiationGabriel R Linares, Robert Brommage, David R Powell, et al.
Pageof 12